Mechanistic Comparison# Dosing Comparison# Amycretin Dosing# Amycretin dosing is investigational: Subcutaneous: Once-weekly injection, doses up to 60 mg studied in phase 1b/2a over 36 weeks Oral: Daily tablet, doses up to 50 mg (or 2 x 50 mg) studied in phase 1 Phase 2 T2D: Both subcutaneous and oral formulations studied over 36 weeks Phase 3 dose selection will be informed by the completed phase 2 data
The formulation helps reduce dark spots, even skin tone, and nourish for a radiant appearance
Its niche is stable and well-defined, keeping it a consistent mid-pack entry
Accumulating evidence indicates that certain probiotic strains can selectively activate these receptors
Allard C, Doyon M, Brown C, Carpentier AC, Langlois MF, Hivert MF
Prescription medications require a valid prescription from a registered medical practitioner